Ca Richard Murray Net Worth & Insider Trades

Ca Richard Murray - CEO and President, Jounce Therapeutics, Inc

As of February 3, 2022

What is Ca Richard Murray's Net Worth?

The current estimated net worth of Jounce Therapeutics, Inc's CEO and President, Ca Richard Murray, is estimated to be about $3.12M . Ca Richard Murray owns about 185,577 units of Jounce Therapeutics, Inc common stock. In the last 4 years at Jounce Therapeutics, Inc, Ca Richard Murray has sold an estimated value of $2.8M worth.

What is Ca Richard Murray's Past Insider Trading?

Ca Richard Murray's largest purchase order was 86,482 units , worth over $41.51K on January 20, 2021. Ca Richard Murray's largest sale order was 86,482 units , worth over $838.24K on January 20, 2021. In total, Ca Richard Murray has made about 14 transactions over 4 years of their time at Jounce Therapeutics, Inc. Ca Richard Murray usually trades in February and January, with the busiest year in 2018 and 2021. The most recent transaction was a sale order of 37,294 units , worth over $256.7K on January 11, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Ca Richard Murray's Salary in 2020?

As CEO and President of Jounce Therapeutics, Inc, Ca Richard Murray has a total base salary of $565,100 . Ca Richard Murray received compensation valued at about $2,003,484 in 2020 after becoming CEO and President. The vast majority of their compensation came in the form of a bonus of $310,810 , stock awards of $491,316 , option awards of $627,312 , and other compensation of $8,946 .

What is Ca Richard Murray's' Mailing Address?

  • Mailing address is 22643 Woodridge Ct Cupertino CA 95014 CA

Jounce Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Richard Murray, Ph.D., 2020 $565,100 $310,810 $491,316 $627,312 $8,946 $2,003,484
Richard Murray, Ph.D., 2019 $540,800 $295,500 $275,044 $348,665 $8,796 $1,468,805
Hugh M. Cole 2020 $420,000 $212,520 $196,500 $250,908 $8,808 $1,088,736
Hugh M. Cole 2019 $401,700 $153,700 $97,900 $124,115 $5,709 $783,124
Kim C. Drapkin 2020 $398,400 $175,300 $174,885 $223,308 $8,688 $980,581
Kim C. Drapkin 2019 $381,200 $145,800 $97,900 $124,115 $8,796 $757,811
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1640455/000164045521000078/jnce042621def14a.htm

What are Jounce Therapeutics, Inc's Past Insider Trades?

Jounce Therapeutics, Inc's most recent insider trade came on January 11, 2022 by Elizabeth Trehu who sold 8,383 units worth $57.7K . In the last 5 years, insiders at Jounce Therapeutics, Inc have sold an estimated value of $42.43M and bought an estimated value of $10.7M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Elizabeth Trehu, Chief Medical Officer,  Kimberlee C Drapkin, CFO and Treasurer,  and Ca Richard Murray, CEO and President .

Jounce Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1